Clinical trial
Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
NCT03266913 is registered in ClinicalTrials.gov with Hormozgan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
- Lead sponsor
- Hormozgan University of Medical Sciences
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 1, 2017
- Completion date
- November 1, 2017
- Enrollment
- 126 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.